No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CRHCRH plc | 81.95B | 122.56 | 24.41 | 12.01% | 9.27% | 13.24% | 2.89% | 0.67 |
| AMRZAmrize Ltd | 30.15B | 54.52 | 23.70 | 0.23% | 11.65% | 10.68% | 5.44% | 0.96 |
| CXCEMEX, S.A.B. de C.V. | 17.92B | 12.35 | 20.25 | -6.83% | 8.61% | 9.8% | 3.34% | 0.59 |
| EXPEagle Materials Inc. | 7.4B | 230.76 | 16.76 | 0.05% | 19.41% | 29.07% | 4.77% | 0.88 |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Sales/Revenue | 10.73B | 11.68B | 11.7B |
| Revenue Growth % | - | 0.09% | 0% |
| Cost of Goods Sold | 8.25B | 8.91B | 8.63B |
| COGS % of Revenue | 0.77% | 0.76% | 0.74% |
| Gross Profit | 2.47B | 2.77B | 3.07B |
| Gross Margin % | 0.23% | 0.24% | 0.26% |
| Gross Profit Growth % | - | 0.12% | 0.11% |
| Operating Expenses | 773M | 881M | 893M |
| OpEx % of Revenue | 0.07% | 0.08% | 0.08% |
| Selling, General & Admin | 752M | 898M | 962M |
| SG&A % of Revenue | 0.07% | 0.08% | 0.08% |
| Research & Development | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | 21M | -17M | -69M |
| Operating Income | 1.7B | 1.89B | 2.18B |
| Operating Margin % | 0.16% | 0.16% | 0.19% |
| Operating Income Growth % | - | 0.11% | 0.15% |
| EBITDA | 2.49B | 2.74B | 3.07B |
| EBITDA Margin % | 0.23% | 0.23% | 0.26% |
| EBITDA Growth % | - | 0.1% | 0.12% |
| D&A (Non-Cash Add-back) | 788M | 851M | 889M |
| EBIT | 1.71B | 1.85B | 2.12B |
| Net Interest Income | -248M | -549M | -302M |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 248M | 549M | 302M |
| Other Income/Expense | -226M | -572M | -344M |
| Pretax Income | 1.47B | 1.32B | 1.83B |
| Pretax Margin % | 0.14% | 0.11% | 0.16% |
| Income Tax | 366M | 361M | 415M |
| Effective Tax Rate % | 0.75% | 0.73% | 0.77% |
| Net Income | 1.11B | 956M | 1.42B |
| Net Margin % | 0.1% | 0.08% | 0.12% |
| Net Income Growth % | - | -0.14% | 0.48% |
| Net Income (Continuing) | 1.11B | 955M | 1.42B |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 1M | 0 | -1M |
| EPS (Diluted) | 2.00 | 1.73 | 2.30 |
| EPS Growth % | - | -0.14% | 0.33% |
| EPS (Basic) | 2.00 | 1.73 | 2.30 |
| Diluted Shares Outstanding | 552.7M | 552.7M | 553.3M |
| Basic Shares Outstanding | 552.7M | 552.7M | 553.3M |
| Dividend Payout Ratio | - | - | - |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Total Current Assets | 3.16B | 3.94B | 4.78B |
| Cash & Short-Term Investments | 351M | 1.11B | 1.58B |
| Cash Only | 351M | 1.11B | 1.58B |
| Short-Term Investments | 0 | 0 | 0 |
| Accounts Receivable | 1.41B | 1.4B | 1.63B |
| Days Sales Outstanding | 47.98 | 43.7 | 50.86 |
| Inventory | 1.23B | 1.31B | 1.45B |
| Days Inventory Outstanding | 54.3 | 53.55 | 61.38 |
| Other Current Assets | 51M | 40M | 20M |
| Total Non-Current Assets | 17.51B | 19.11B | 19.02B |
| Property, Plant & Equipment | 7.75B | 8.07B | 8.08B |
| Fixed Asset Turnover | 1.38x | 1.45x | 1.45x |
| Goodwill | 8.12B | 8.97B | 8.92B |
| Intangible Assets | 1.44B | 1.88B | 1.83B |
| Long-Term Investments | 0 | 0 | 56M |
| Other Non-Current Assets | 202M | 184M | 138M |
| Total Assets | 20.67B | 23.05B | 23.8B |
| Asset Turnover | 0.52x | 0.51x | 0.49x |
| Asset Growth % | - | 0.11% | 0.03% |
| Total Current Liabilities | 2.25B | 2.44B | 2.55B |
| Accounts Payable | 1.14B | 1.25B | 1.29B |
| Days Payables Outstanding | 50.59 | 51.14 | 54.66 |
| Short-Term Debt | 348M | 131M | 348M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K |
| Other Current Liabilities | 464M | 532M | 392M |
| Current Ratio | 1.40x | 1.61x | 1.87x |
| Quick Ratio | 0.86x | 1.08x | 1.31x |
| Cash Conversion Cycle | 51.7 | 46.12 | 57.59 |
| Total Non-Current Liabilities | 10.21B | 11.4B | 11.34B |
| Long-Term Debt | 7.62B | 8.64B | 8.5B |
| Capital Lease Obligations | 516M | 564M | 698M |
| Deferred Tax Liabilities | 944M | 998M | 1.1B |
| Other Non-Current Liabilities | 873M | 930M | 701M |
| Total Liabilities | 12.46B | 13.84B | 13.89B |
| Total Debt | 8.66B | 9.52B | 9.54B |
| Net Debt | 8.31B | 8.42B | 7.96B |
| Debt / Equity | 1.05x | 1.03x | 0.96x |
| Debt / EBITDA | 3.48x | 3.48x | 3.11x |
| Net Debt / EBITDA | 3.34x | 3.07x | 2.60x |
| Interest Coverage | 6.85x | 3.44x | 7.21x |
| Total Equity | 8.21B | 9.2B | 9.91B |
| Equity Growth % | - | 0.12% | 0.08% |
| Book Value per Share | 14.85 | 16.65 | 17.92 |
| Total Shareholders' Equity | 8.21B | 9.2B | 9.91B |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 |
| Accumulated OCI | -372M | -317M | 9.91B |
| Minority Interest | 1M | 0 | -1M |
| Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|
| Cash from Operations | 1.99B | 2.04B | 2.28B |
| Operating CF Margin % | 0.19% | 0.17% | 0.19% |
| Operating CF Growth % | - | 0.02% | 0.12% |
| Net Income | 1.11B | 955M | 1.27B |
| Depreciation & Amortization | 788M | 851M | 889M |
| Stock-Based Compensation | 4M | 5M | 6M |
| Deferred Taxes | 66M | 11M | -35M |
| Other Non-Cash Items | 9M | 97M | 111M |
| Working Capital Changes | 14M | 117M | 38M |
| Change in Receivables | 35M | -82M | 189M |
| Change in Inventory | -296M | -7M | -146M |
| Change in Payables | 195M | 60M | 28M |
| Cash from Investing | -2.52B | -2.02B | -1.21B |
| Capital Expenditures | -488M | -630M | -642M |
| CapEx % of Revenue | 0.05% | 0.05% | 0.05% |
| Acquisitions | - | - | - |
| Investments | - | - | - |
| Other Investing | 0 | 212M | -317M |
| Cash from Financing | 497M | 734M | -537M |
| Debt Issued (Net) | - | - | - |
| Equity Issued (Net) | - | - | - |
| Dividends Paid | 0 | 0 | 0 |
| Share Repurchases | - | - | - |
| Other Financing | -228M | -13M | -312M |
| Net Change in Cash | - | - | - |
| Free Cash Flow | 1.5B | 1.41B | 1.64B |
| FCF Margin % | 0.14% | 0.12% | 0.14% |
| FCF Growth % | - | -0.06% | 0.17% |
| FCF per Share | 2.71 | 2.54 | 2.96 |
| FCF Conversion (FCF/Net Income) | 1.79x | 2.13x | 1.61x |
| Interest Paid | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Return on Equity (ROE) | 13.5% | 10.98% | 14.85% |
| Return on Invested Capital (ROIC) | 7.71% | 8.3% | 9.2% |
| Gross Margin | 23.05% | 23.71% | 26.23% |
| Net Margin | 10.33% | 8.19% | 12.12% |
| Debt / Equity | 1.05x | 1.03x | 0.96x |
| Interest Coverage | 6.85x | 3.44x | 7.21x |
| FCF Conversion | 1.79x | 2.13x | 1.61x |
| Revenue Growth | - | 8.87% | 0.23% |
Amrize Ltd (AMRZ) has a price-to-earnings (P/E) ratio of 23.7x. This is roughly in line with market averages.
Amrize Ltd (AMRZ) reported $11.82B in revenue for fiscal year 2024. This represents a 10% increase from $10.73B in 2022.
Amrize Ltd (AMRZ) grew revenue by 0.2% over the past year. Growth has been modest.
Yes, Amrize Ltd (AMRZ) is profitable, generating $1.38B in net income for fiscal year 2024 (12.1% net margin).
Amrize Ltd (AMRZ) has a return on equity (ROE) of 14.8%. This is reasonable for most industries.
Amrize Ltd (AMRZ) generated $1.42B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.